000 02881nam a22003615i 4500
999 _c100183
_d100183
_x1
001 100183
003 DE-He213
005 20230110040207.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 171214s2018 gw | s |||| 0|eng d
020 _a9783658205911
024 7 _a10.1007/978-3-658-20591-1
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC254.5
_bK785 2018 EB
100 1 _aKrukemeyer, Manfred Georg.
_eautor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_0http://id.loc.gov/authorities/names/n2006072601
245 1 0 _aExperimental Investigations into Sarcomas:
_bTherapy Using Ferromagnetically Induced Cytostatics
_cby Manfred Georg Krukemeyer.
264 1 _aWiesbaden
_bSpringer International Publishing
_c2018
300 _a1 recurso en línea (XII, 122 páginas 39 ilustraciones, 21 ilustraciones a color)
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
520 3 _aManfred Georg Krukemeyer first describes magnetic drug targeting, by which is meant the focused application of drugs, e.g. the introduction of a cytostatic, and which is aimed at optimising its locally therapeutic effect. The author thus achieves a high concentration of cytostatic at the site of the tumour. The particles have to be large enough to be attracted by a magnetic field and so find their way into the tumour, where they release their active ingredient. The aim of the hypothesis formed by one of the author's study groups was to show in a scientific experiment that in this case cytostatics coupled with iron particles [Fe3O4] can be introduced into a tumour. The focused introduction of drugs - magnetic drug targeting - results in faster arrival of the active ingredient at the target site together with a reduced quantity of active substances. For this reason magnetic drug targeting is also interesting from an economic point of view. Contents Sarcomas and their Pathology  Magnetic Drug Targeting Animal Testing and Patient Examination, Tumour Therapy in Humans  Target groups Researchers, teachers and students in surgical and oncology departments Doctors working in the fields of surgery and oncology  About the author Dr. med. Manfred Georg Krukemeyer is a specialist surgeon currently holding a senior position at a large German hospital enterprise.
988 _aSpringer_Medicine_2018
650 7 _2embne
_aOncología
_9139207
776 0 8 _iEdición impresa:
_z9783658205904
776 0 8 _iEdición impresa:
_z9783658205928
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-658-20591-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE